Simplex Trading’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.27K | Sell |
50
-6
| -11% | -$142 | ﹤0.01% | 8785 |
|
|
2026
Q1 | $1.26K | Buy |
+56
| New | +$1.25K | ﹤0.01% | 8520 |
|
|
2025
Q3 | – | Sell |
-1,598
| Closed | -$39.3K | – | 9800 |
|
|
2025
Q2 | $38K | Sell |
1,598
-2,386
| -60% | -$60.1K | ﹤0.01% | 6190 |
|
|
2025
Q1 | $99K | Sell |
3,984
-12,608
| -76% | -$302K | ﹤0.01% | 5073 |
|
|
2024
Q4 | $312K | Buy |
+16,592
| New | +$291K | ﹤0.01% | 4028 |
|
|
2024
Q2 | – | Sell |
-2,281
| Closed | -$64.9K | – | 9558 |
|
|
2024
Q1 | $66K | Buy |
+2,281
| New | +$70.1K | ﹤0.01% | 6009 |
|
|
2023
Q2 | – | Sell |
-561
| Closed | -$23.2K | – | 9687 |
|
|
2023
Q1 | $22K | Sell |
561
-110
| -16% | -$4.38K | ﹤0.01% | 6823 |
|
|
2022
Q4 | $25K | Buy |
+671
| New | +$32.6K | ﹤0.01% | 6660 |
|
|
2022
Q1 | – | Sell |
-1,041
| Closed | -$69.4K | – | 11141 |
|
|
2021
Q4 | $62K | Buy |
+1,041
| New | +$57.4K | ﹤0.01% | 6947 |
|
|
2020
Q2 | – | Sell |
-1,565
| Closed | -$65.4K | – | 8153 |
|
|
2020
Q1 | $52K | Buy |
+1,565
| New | +$65K | ﹤0.01% | 5083 |
|
|
2019
Q2 | – | Sell |
-14,006
| Closed | -$595K | – | 7598 |
|
|
2019
Q1 | $533K | Sell |
14,006
-19,173
| -58% | -$748K | ﹤0.01% | 2599 |
|
|
2018
Q4 | $1.43M | Buy |
33,179
+8,996
| +37% | +$420K | ﹤0.01% | 1337 |
|
|
2018
Q3 | $1.19M | Buy |
24,183
+22,709
| +1,541% | +$982K | ﹤0.01% | 1716 |
|
|
2018
Q2 | $47K | Sell |
1,474
-21,739
| -94% | -$751K | ﹤0.01% | 5124 |
|
|
2018
Q1 | $723K | Buy |
23,213
+8,475
| +58% | +$302K | 0.03% | 530 |
|
|
2017
Q4 | $672K | Sell |
14,738
-21,221
| -59% | -$841K | 0.03% | 561 |
|
|
2017
Q3 | $1.35M | Buy |
+35,959
| New | +$1.45M | 0.06% | 285 |
|
|
2017
Q1 | – | Sell |
-27,152
| Closed | -$1.17M | – | 6633 |
|
|
2016
Q4 | $877K | Buy |
27,152
+25,193
| +1,286% | +$841K | 0.05% | 304 |
|
|
2016
Q3 | $67K | Sell |
1,959
-6,697
| -77% | -$262K | ﹤0.01% | 1859 |
|
|
2016
Q2 | $291K | Buy |
8,656
+7,137
| +470% | +$351K | 0.02% | 790 |
|
|
2016
Q1 | $80K | Sell |
1,519
-5,285
| -78% | -$309K | 0.01% | 1544 |
|
|
2015
Q4 | $522K | Buy |
6,804
+6,625
| +3,701% | +$375K | 0.04% | 416 |
|
|
2015
Q3 | $7K | Buy |
+179
| New | +$11K | ﹤0.01% | 3754 |
|
Other funds holding PCRX
DPCM
Simplex Trading's PCRX Position: Q2 2026 in Review
Simplex Trading reduced its Pacira BioSciences (PCRX) stake by 11% in Q2 2026, selling an estimated $142 and leaving 50 shares worth $1.27K. The position accounts for ﹤0.01% of the portfolio, ranked #8785.
Simplex Trading first reported a position in PCRX in Q3 2015 and has held it in 23 quarters since. The position peaked at $1.43M in Q4 2018. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.
- Simplex Trading held 50 shares of Pacira BioSciences worth $1.27K as of Q2 2026.
- Simplex Trading sold 6 Pacira BioSciences shares in Q2 2026, an estimated $142.
- Pacira BioSciences made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #8785 holding.
- Simplex Trading first reported a position in Pacira BioSciences in Q3 2015 and has held it in 23 quarters since.
- Simplex Trading's Pacira BioSciences position peaked at $1.43M in Q4 2018.
- 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.